期刊
ARCHIVES OF PHARMACAL RESEARCH
卷 42, 期 5, 页码 416-425出版社
PHARMACEUTICAL SOC KOREA
DOI: 10.1007/s12272-019-01133-0
关键词
Parkinson's disease; Neuroinflammation; Glia; A1 astrocyte; A2 astrocyte; Microglia
资金
- National Research Foundation of Korea (NRF) [2018R1D1A1B07043493]
- National Research Foundation of Korea [2018R1D1A1B07043493] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Glial cells outnumber neurons in the brain and play important roles in the neuroinflammation that accompanies brain damage in neurodegenerative diseases. In Parkinson's disease (PD), dopaminergic neuronal loss is accompanied by inflammatory changes in microglia, astrocytes, innate immune cells, and infiltrating peripheral immune cells. Neuroinflammation is probably a fundamental immune response to protect neurons from harm and compensate for neuronal damage, but at the same time, its neurotoxic effects exacerbate neuron damage. Furthermore, neuroinflammatory response is regulated by immune cells, such as microglia, astrocytes, and peripheral immune cells, and by cytokines and chemokines. Accordingly, it is crucial that we understand how such immune cells in the brain regulate neuroinflammatory responses in PD pathology. This review describes the roles played by glia-mediated neuroinflammation in PD, both good and bad, and the therapeutic strategies used to treat PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据